SCHEMBL7174496

SCHEMBL7174496

Cc1ccnc(NCCCC(=O)NCC(=O)NC(CC(=O)O)c2ccc(-c3ccc4ccccc4c3)cc2)c1.[Na]

nearest known ligand 0.78

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ITGAV P06756 17/20 0.78
ITGB3 P05106 16/20 0.78
ITGB6 P18564 8/20 0.78
ITGB5 P18084 7/20 0.78
ITGA2B P08514 6/20 0.78
ITGB1 P05556 1/20 0.72
ITGA5 P08648 1/20 0.72
CTSA P10619 1/20 0.43
MAPK8 P45983 1/20 0.40
GSK3A P49840 1/20 0.40
MAPK10 P53779 1/20 0.40
HIPK1 Q86Z02 1/20 0.40
RIOK2 Q9BVS4 1/20 0.40
SNRK Q9NRH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6671946 0.99 ITGAV (0.79) ITGAVITGB3ITGB6ITGB5ITGA2B
SCHEMBL7174477 0.98 ITGAV (0.78) ITGAVITGB3ITGB6ITGB5ITGA2B
SCHEMBL7172659 0.98 ITGAV (0.74) ITGAVITGB3ITGB6ITGB5ITGA2B
SCHEMBL6670185 0.97 ITGAV (0.75) ITGAVITGB3ITGB6ITGB5ITGA2B
SCHEMBL7172643 0.96 ITGAV (0.74) ITGAVITGB3ITGB6ITGB5ITGA2B
Trifluoroacetic Acid SCHEMBL6668017 0.95 ITGAV (0.81) ITGAVITGB3ITGB6ITGB5ITGA2B
SCHEMBL7170092 0.94 ITGAV (0.79) ITGAVITGB3ITGB6ITGB5ITGA2B
SCHEMBL6668568 0.93 ITGAV (0.81) ITGAVITGB3ITGB6ITGB5ITGA2B
Trifluoroacetic Acid SCHEMBL6683132 0.93 ITGAV (0.77) ITGAVITGB3ITGB6ITGB5ITGA2B
SCHEMBL7174484 0.92 ITGAV (0.68) ITGAVITGB3ITGB6ITGB5ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6576637-B1 Such as 3-(4-methyl-3-nitrophenyl)-3-(2-(4-(pyridin-2-yl-amino)butyryl amino)acetylamino)propionic acid; thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations, MERCK PATENT GMBH (DE) 2003-06-10 US disclosed